Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
Open Access
- 1 August 2021
- journal article
- review article
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 17, 2549-2566
Abstract
Chronic insomnia disorder, which affects 6– 10% of the population, is diagnostically characterized by ongoing difficulties with initiating or maintaining sleep occurring at least three times per week, persisting for at least 3 months, and associated with daytime impairment. While chronic insomnia is often considered a condition primarily related to impaired sleep, the disorder can also adversely affect domains of physical and mental health, quality of life, and daytime function, which highlights the importance of treating the multidimensional sleep disorder. Owing to misperceptions about the safety and effectiveness of treatment options, many individuals with insomnia may not seek professional treatment, and alternatively use ineffective home remedies or over-the-counter medications to improve sleep. Some physicians may even believe that insomnia is remediated by simply having the patient “get more sleep”. Unfortunately, treatment of insomnia is not always that simple. The disorder’s complex underlying pathophysiology warrants consideration of different nonpharmacologic and pharmacologic treatment options. Indeed, recent insights gained from research into the pathophysiology of insomnia have facilitated development of newer treatment approaches with more efficacious outcomes. This narrative review provides a summary of the diagnostic criteria and pathophysiology of insomnia and its subtypes. Further, this review emphasizes new and emerging nonpharmacologic and pharmacologic treatments for chronic insomnia, including recent enhancements in approaches to cognitive behavioral therapy for insomnia (CBT-I) and the new dual orexin receptor antagonist (DORA) pharmacologics. These advances in treatment have expanded the treatment options and are likely to result in improved outcomes in patients with chronic insomnia.Keywords
This publication has 143 references indexed in Scilit:
- Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep, and EEG Power Spectra in a Model of Situational InsomniaNeuropsychopharmacology, 2012
- Efficacy of Brief Behavioral Treatment for Chronic Insomnia in Older AdultsArchives of internal medicine (1960), 2011
- Drug-Related Sleep Stage Changes: Functional Significance and Clinical RelevanceSleep Medicine Clinics, 2010
- Insomnia severity is an indicator of suicidal ideation during a depression clinical trialSleep Medicine, 2010
- A mindfulness‐based approach to the treatment of insomniaJournal of Clinical Psychology, 2010
- Distinguishing rumination from worry in clinical insomniaBehaviour Research and Therapy, 2010
- Good night and good luck: Norepinephrine in sleep pharmacologyBiochemical Pharmacology, 2010
- Management of Hypnotic Discontinuation in Chronic InsomniaSleep Medicine Clinics, 2009
- Cognitive Behavioral Therapy, Singly and Combined With Medication, for Persistent InsomniaJAMA, 2009
- Combining Mindfulness Meditation with Cognitive-Behavior Therapy for Insomnia: A Treatment-Development StudyBehavior Therapy, 2008